Cargando…
Platelet-Rich Plasma Treatment for Chronic Respiratory Disease
This study was conducted to test the hypothesis that platelet-rich plasma (PRP) therapy in chronic respiratory disease patients will cause lung regeneration, thereby slowing the progression of the disease. We performed a search to obtain pertinent articles on the following electronic databases: Goog...
Autores principales: | Knight, Aaron D, Kacker, Sandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891651/ https://www.ncbi.nlm.nih.gov/pubmed/36741673 http://dx.doi.org/10.7759/cureus.33265 |
Ejemplares similares
-
Platelet-Rich Plasma: A Promising Regenerative Therapy in Gynecological Disorders
por: Varghese, Jerin, et al.
Publicado: (2022) -
Platelet-rich plasma in patients affected with Peyronie’s disease
por: Achraf, Chatar, et al.
Publicado: (2022) -
Can Phosphodiesterase 4 Inhibitor Therapy Be Used in Respiratory Diseases Other Than Chronic Obstructive Pulmonary Disease?
por: Goonathilake, Mastiyage R, et al.
Publicado: (2022) -
Measurement of Procalcitonin as an Indicator of Severity in Patients With Chronic Obstructive Pulmonary Disease Admitted With Respiratory Illness
por: Davies, Alexander J, et al.
Publicado: (2022) -
Current State of Platelet-rich Plasma in the Treatment of Rheumatic Disease: A Retrospective Review of the Literature
por: Jacobs, Adam, et al.
Publicado: (2023)